Earnings Call · Q4 FY2024·2024-05-10

Q4 24EPS +1.12%·Rev n/aQ3 24EPS +10.64%·Rev n/aQ2 24EPS +11.24%·Rev n/aQ1 24EPS +43.84%·Rev n/a⚠ consensus missing

HAEMONETICS CORP HAE

Olga Guyette — Investor Relations

Christopher Simon — Chief Executive Officer

James D'Arecca — Chief Financial Officer

−0.7%1d on move date−1.3% vs SPY3d+3.2%5d+3.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more HAE calls or request research access.

More HAE calls Browse calls Request research access